Dover’s CPC Biotech Expands Bioprocessing Portfolio with High-Temperature Connector
Event summary
- CPC Biotech, a Dover subsidiary, launched the AseptiQuik G PPSU HT Series connectors on April 20, 2026.
- The connectors are made of polyphenylsulfone (PPSU), compatible with gamma and autoclave sterilization, and can withstand a wide pH range (2 to 12) and harsh chemicals.
- The new connectors are distinguished by a gold-colored tab and are available in sizes to fit hose barbs of 1/4", 3/8", 1/2", and 3/4", as well as 3/4" sanitary fittings.
- CPC Biotech is part of Pump Solutions Group (PSG), an operating company within Dover Corporation.
The big picture
Dover’s CPC Biotech is reinforcing its position in the bioprocessing fluid management sector with the launch of the AseptiQuik G PPSU HT Series connectors. This move aligns with the broader industry trend towards more robust and versatile components that can handle a wider range of chemicals and sterilization methods. The connectors' compatibility with both gamma and autoclave sterilization, along with their ability to withstand extreme pH levels, positions Dover to capture a larger share of the biopharmaceutical processing market. The launch also underscores Dover’s strategy of leveraging its subsidiaries to drive innovation in critical fluid management solutions.
What we're watching
- Market Adoption
- How quickly biopharmaceutical companies will integrate the new connectors into their high-temperature and harsh chemical processes.
- Competitive Response
- Whether competitors will introduce similar high-compatibility connectors, potentially intensifying the market competition.
- Operational Efficiency
- The impact of the connectors' seamless integration with existing AseptiQuik products on operational efficiency and cost savings for bioprocessors.
Related topics